AU3517900A - Methods for mitochondrial gene therapy - Google Patents

Methods for mitochondrial gene therapy

Info

Publication number
AU3517900A
AU3517900A AU35179/00A AU3517900A AU3517900A AU 3517900 A AU3517900 A AU 3517900A AU 35179/00 A AU35179/00 A AU 35179/00A AU 3517900 A AU3517900 A AU 3517900A AU 3517900 A AU3517900 A AU 3517900A
Authority
AU
Australia
Prior art keywords
methods
gene therapy
mitochondrial gene
mitochondrial
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35179/00A
Inventor
Jerome M. Eisenstadt
Steven J. Zullo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU3517900A publication Critical patent/AU3517900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU35179/00A 1999-03-08 2000-03-08 Methods for mitochondrial gene therapy Abandoned AU3517900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12333699P 1999-03-08 1999-03-08
US60123336 1999-03-08
PCT/US2000/006037 WO2000053773A2 (en) 1999-03-08 2000-03-08 Methods for mitochondrial gene therapy

Publications (1)

Publication Number Publication Date
AU3517900A true AU3517900A (en) 2000-09-28

Family

ID=22408080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35179/00A Abandoned AU3517900A (en) 1999-03-08 2000-03-08 Methods for mitochondrial gene therapy

Country Status (2)

Country Link
AU (1) AU3517900A (en)
WO (1) WO2000053773A2 (en)

Also Published As

Publication number Publication date
WO2000053773A2 (en) 2000-09-14
WO2000053773A3 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU1050401A (en) Device for cardiac therapy
AU2879300A (en) Methods for anti-tumor therapy
AU7319800A (en) 4-oxybenzopyran derivative
AUPQ262599A0 (en) Gene expression
AU7453900A (en) 4-oxybenzopyran derivative
AU1538901A (en) Polymersation process
AU2451500A (en) Therapeutic agents
AU1645700A (en) Oenothein medicaments
AU2376200A (en) Insulin-synthesis genes
AU2732000A (en) Reverse gene therapy
AU5973600A (en) Therapeutic agents
AU4599500A (en) Safe
AU7818100A (en) Travel safe
GB0025890D0 (en) Gene therapy
AU6001200A (en) Expression system
AU5088600A (en) Gene therapy products
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AU3517900A (en) Methods for mitochondrial gene therapy
AU4552700A (en) Gene therapy
GB0406539D0 (en) Gene therapy
AU6150200A (en) Therapeutic agents
AU3061500A (en) Wheels
AU3447900A (en) Assay for therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase